Inspire Medical Systems Return on Tangible Equity 2017-2025 | INSP
Current and historical return on tangible equity values for Inspire Medical Systems (INSP) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Inspire Medical Systems Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.05B | $0.68B | 7.70% |
| 2025-03-31 | $0.07B | $0.64B | 9.92% |
| 2024-12-31 | $0.05B | $0.69B | 8.11% |
| 2024-09-30 | $0.03B | $0.70B | 5.29% |
| 2024-06-30 | $0.01B | $0.64B | 1.02% |
| 2024-03-31 | $-0.02B | $0.59B | -2.86% |
| 2023-12-31 | $-0.02B | $0.57B | -3.91% |
| 2023-09-30 | $-0.03B | $0.54B | -6.36% |
| 2023-06-30 | $-0.04B | $0.53B | -8.20% |
| 2023-03-31 | $-0.04B | $0.51B | -10.13% |
| 2022-12-31 | $-0.05B | $0.50B | -12.69% |
| 2022-09-30 | $-0.05B | $0.47B | -17.38% |
| 2022-06-30 | $-0.04B | $0.23B | -19.09% |
| 2022-03-31 | $-0.04B | $0.23B | -18.79% |
| 2021-12-31 | $-0.04B | $0.23B | -18.39% |
| 2021-09-30 | $-0.05B | $0.22B | -20.60% |
| 2021-06-30 | $-0.05B | $0.22B | -20.40% |
| 2021-03-31 | $-0.06B | $0.22B | -24.45% |
| 2020-12-31 | $-0.06B | $0.23B | -27.32% |
| 2020-09-30 | $-0.06B | $0.23B | -31.78% |
| 2020-06-30 | $-0.06B | $0.23B | -34.62% |
| 2020-03-31 | $-0.04B | $0.13B | -29.03% |
| 2019-12-31 | $-0.03B | $0.14B | -22.18% |
| 2019-09-30 | $-0.03B | $0.15B | -18.74% |
| 2019-06-30 | $-0.03B | $0.15B | -18.21% |
| 2019-03-31 | $-0.02B | $0.16B | -18.39% |
| 2018-12-31 | $-0.02B | $0.16B | -25.56% |
| 2018-09-30 | $-0.02B | $0.10B | -44.67% |
| 2018-06-30 | $-0.02B | $0.10B | -84.85% |
| 2018-03-31 | $-0.02B | $-0.01B | 2000.00% |
| 2017-12-31 | $-0.02B | $0.00B | -6800.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.509B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.084B | 58.67 |
| Tempus AI (TEM) | United States | $12.183B | 0.00 |
| Doximity (DOCS) | United States | $9.342B | 38.47 |
| Hims & Hers Health (HIMS) | United States | $8.418B | 68.48 |
| IRhythm Technologies (IRTC) | United States | $5.504B | 0.00 |
| Hinge Health (HNGE) | United States | $3.224B | 0.00 |
| Privia Health (PRVA) | United States | $2.884B | 180.38 |
| Heartflow (HTFL) | United States | $2.383B | 0.00 |
| 10x Genomics (TXG) | United States | $2.011B | 0.00 |
| Enovis (ENOV) | United States | $1.715B | 9.01 |
| Omnicell (OMCL) | United States | $1.576B | 32.22 |
| Azenta (AZTA) | United States | $1.364B | 59.50 |
| Phreesia (PHR) | United States | $1.304B | 0.00 |
| Schrodinger (SDGR) | United States | $1.299B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.900B | 0.00 |
| Claritev (CTEV) | United States | $0.715B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 108.33 |
| Butterfly Network (BFLY) | United States | $0.536B | 0.00 |
| Veradigm (MDRX) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.466B | 0.00 |
| Carlsmed (CARL) | United States | $0.349B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.05 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.239B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.212B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.200B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.172B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.160B | 0.00 |
| CareCloud (CCLD) | United States | $0.133B | 7.28 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.085B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.045B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.031B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.025B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |